Literature DB >> 8619884

Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta.

J Hakkola1, M Pasanen, J Hukkanen, O Pelkonen, J Mäenpää, R J Edwards, A R Boobis, H Raunio.   

Abstract

The expression of individual xenobiotic-metabolizing cytochrome P450 (CYP) genes in human placenta was studied at the mRNA level by reverse transcriptase-polymerase chain reaction (RT-PCR). mRNAs of CYP1A1, CYP2E1, CYP2F1, CYP3A3/4, CYP3A5, and CYP4B1 were detected by RT-PCR, and CYP1A2, CYP2A6/7, CYP2B6/7, CYp2C8-19, CYP2D6, and CYp3A7 were not detected. Several enzyme activity assays and immunoblasts were used to further characterize expression of forms producing detectable mRNA transcripts. The catalytic activities of 7-ethoxycoumarin O-deethylase (ECOD), 7-ethoxyresorufin O-deethylase (EROD) and aryl hydrocarbon hydroxylase (AHH) were substantially increased in response to maternal cigarette smoking, and paralleled the amount of CYP1A1 mRNA and protein. Aromatase activities were slightly lower in placentas exposed to cigarette smoke compared with nonexposed placentas. These data show that several xenobiotic-metabolizing CYP genes are expressed in human placenta at a low level. The significant of such low-level expression is unknown, but it may have local physiological or toxic consequences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8619884     DOI: 10.1016/0006-2952(95)02184-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  27 in total

1.  Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.

Authors:  S J Hughes; M A Morse; C M Weghorst; H Kim; P B Watkins; F P Guengerich; M B Orringer; D G Beer
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes Mellitus.

Authors:  Elaine Christine Dantas Moises; Luciana de Barros Duarte; Ricardo de Carvalho Cavalli; Daniela Miarelli Carvalho; Gabriela Campos de Oliveira Filgueira; Maria Paula Marques; Vera Lucia Lanchote; Geraldo Duarte
Journal:  Reprod Sci       Date:  2015-01-05       Impact factor: 3.060

3.  Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.

Authors:  Sara K Quinney; Tara Benjamin; Xiaomei Zheng; Avinash S Patil
Journal:  Fetal Pediatr Pathol       Date:  2017-09-26       Impact factor: 0.958

Review 4.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Acetylation of arylamines by the placenta.

Authors:  V A Smelt; H J Mardon; C W Redman; E Sim
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

Review 6.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

7.  Maternal obesity alters feto-placental cytochrome P4501A1 activity.

Authors:  B N DuBois; P O'Tierney-Ginn; J Pearson; J E Friedman; K Thornburg; G Cherala
Journal:  Placenta       Date:  2012-10-06       Impact factor: 3.481

8.  Differential gene expression in human conducting airway surface epithelia and submucosal glands.

Authors:  Anthony J Fischer; Kelli L Goss; Todd E Scheetz; Christine L Wohlford-Lenane; Jeanne M Snyder; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

Review 9.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

10.  Novel biomarkers of prenatal methamphetamine exposure in human meconium.

Authors:  Teresa R Gray; Tamsin Kelly; Linda L LaGasse; Lynne M Smith; Chris Derauf; William Haning; Penny Grant; Rizwan Shah; Amelia Arria; Arthur Strauss; Barry M Lester; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2009-02       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.